BAM
MD icon

Belpointe Asset Management’s Pediatrix Medical MD Stock Holding History

Belpointe Asset Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-135
Closed -$2.01K – 2202
2023
Q1 		$2.01K Buy
+135
New +$2.04K ﹤0.01% 3303

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Belpointe Asset Management's MD Position: Q2 2023 in Review

Belpointe Asset Management sold out of Pediatrix Medical (MD) in Q2 2023, closing a stake of 135 shares — an estimated $2.01K sold.

Belpointe Asset Management first reported a position in MD in Q1 2023 and held it in 1 quarter. The position peaked at $2.01K in Q1 2023. 215 funds tracked by Wall St. Rank hold MD as of Q2 2023.

  • Belpointe Asset Management reported no remaining Pediatrix Medical position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 135 Pediatrix Medical shares in Q2 2023, an estimated $2.01K.
  • Belpointe Asset Management first reported a position in Pediatrix Medical in Q1 2023 and held it in 1 quarter.
  • Belpointe Asset Management's Pediatrix Medical position peaked at $2.01K in Q1 2023.
  • 215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.